12:00 AM
 | 
Jan 18, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Hexvix hexyl aminolevulinate regulatory update

Photocure said it received reimbursement approval in Germany for Hexvix to diagnose bladder cancer. The company said the newly-issued code grants reimbursement...

Read the full 87 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >